TFCP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.284800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.037400E-01
Normal-vs-Stage2
8.603200E-01
Normal-vs-Stage3
9.906100E-02
Normal-vs-Stage4
5.160200E-01
Stage1-vs-Stage2
5.550000E-01
Stage1-vs-Stage3
2.395900E-03
Stage1-vs-Stage4
3.935600E-01
Stage2-vs-Stage3
2.389600E-02
Stage2-vs-Stage4
2.456200E-01
Stage3-vs-Stage4
4.955300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.770800E-01
Normal-vs-AfricanAmerican
8.592000E-01
Normal-vs-Asian
3.194000E-01
Caucasian-vs-AfricanAmerican
8.048000E-01
Caucasian-vs-Asian
6.211500E-02
AfricanAmerican-vs-Asian
2.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.265000E-01
Normal-vs-Female
7.447000E-01
Male-vs-Female
1.134190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.709800E-01
Normal-vs-Age(41-60Yrs)
8.674400E-01
Normal-vs-Age(61-80Yrs)
8.341400E-01
Normal-vs-Age(81-100Yrs)
9.445200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.063800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.874200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.652800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.911630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.389600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.359000E-01
Normal-vs-Daily Drinker
5.718400E-01
Normal-vs-Weekly Drinker
5.440600E-01
Normal-vs-Occasional Drinker
5.026800E-01
Normal-vs-Social Drinker
7.629200E-01
Non Drinker-vs-Daily Drinker
9.354200E-01
Non Drinker-vs-Weekly Drinker
7.920600E-01
Non Drinker-vs-Occasional Drinker
8.242300E-03
Non Drinker-vs-Social Drinker
7.838200E-02
Daily Drinker-vs-Weekly Drinker
7.580000E-01
Daily Drinker-vs-Occasional Drinker
1.605920E-02
Daily Drinker-vs-Social Drinker
1.156010E-01
Weekly Drinker-vs-Occasional Drinker
2.572400E-02
Weekly Drinker-vs-Social Drinker
1.319000E-01
Occasional Drinker-vs-Social Drinker
6.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.790000E-02
Normal-vs-Grade 2
1.855970E-02
Normal-vs-Grade 3
2.030400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.920980E-01
Grade 1-vs-Grade 3
6.057600E-01
Grade 1-vs-Grade 4
7.790000E-02
Grade 2-vs-Grade 3
2.057000E-01
Grade 2-vs-Grade 4
1.855970E-02
Grade 3-vs-Grade 4
2.030400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.070200E-01
Normal-vs-NonDiabetic
9.025400E-01
Diabetic-vs-NonDiabetic
2.874400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.144800E-01
Normal-vs-NoPancreatitis
8.933000E-01
Pancreatitis-vs-NoPancreatitis
1.415580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.604800E-01
Normal-vs-N1
9.023600E-01
N0-vs-N1
8.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.762000E-01
Normal-vs-TP53-NonMutant
6.836800E-01
TP53-Mutant-vs-TP53-NonMutant
8.420600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
